Seek Returns

ABBV vs. ORCL: AbbVie vs. Oracle Stock Comparison

How do AbbVie (ABBV) and Oracle (ORCL) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

AbbVie (ABBV) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Oracle (ORCL) belongs to Information Technology (Software & Services) — their GICS classifications point to very different parts of the market.

Company profile comparison for AbbVie (ABBV) and Oracle (ORCL)
Profile ItemABBVORCL
NameAbbVie Inc.Oracle Corporation
Country/RegionUnited StatesUnited States
GICS SectorHealth CareInformation Technology
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesSoftware & Services
GICS IndustryBiotechnologySoftware
GICS Sub-IndustryBiotechnologySystems Software
Market Capitalization514.92 billion USD361.97 billion USD
CurrencyUSDUSD
ExchangeNYSENYSE
Listing DateJanuary 2, 2013March 12, 1986
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

ABBV
ORCL
GSPC
Loading price history…
AbbVie (ABBV) vs. Oracle (ORCL), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for AbbVie (ABBV) and Oracle (ORCL). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for AbbVie (ABBV) and Oracle (ORCL). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for AbbVie (ABBV) and Oracle (ORCL)
MetricABBVORCL
Total Return (1Y)37.33%-49.72%
Total Return (3Y, Annualized)32.74%3.11%
Total Return (5Y, Annualized)24.73%6.07%

Risk Profile

Drawdown History

ABBV
ORCL
GSPC
Loading price history…
AbbVie (ABBV) vs. Oracle (ORCL), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for AbbVie (ABBV) and Oracle (ORCL). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Oracle (ORCL) has an aggressive beta of 1.80, indicating higher sensitivity to broad-market moves, while AbbVie (ABBV) is defensive at 0.21 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk profile metrics for AbbVie (ABBV) and Oracle (ORCL)
MetricABBVORCL
Volatility (1Y, Annualized)25.65%59.45%
Beta (5Y)0.211.80
Max Drawdown (5Y)-21.92%-64.58%
Avg. Volume (3M)4.76M33.24M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
ABBV and ORCL are plotted by 1-year volatility (risk) and 1-year return. Each dashed Capital Allocation Line uses that stock's own industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for AbbVie (ABBV) and Oracle (ORCL)
MetricABBVORCL
Sharpe Ratio (1Y)1.29-0.91
Sortino Ratio (1Y)2.02-1.29

Profitability

ROE (TTM)

Capital efficiency shows on one side only: Oracle (ORCL) earns 41.19% on shareholders’ equity, ranked against its industry; AbbVie (ABBV) has no ROE this period.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
109.18%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
ABBV
--

ORCL

Software & Services industry group

41.19%

Max
53.85%
ORCL
41.19%
Q3
17.90%
Median
6.59%
Q1
-9.59%
Min
-50.52%
Loading chart…
AbbVie (ABBV) vs. Oracle (ORCL): ABBV does not report ROE, so it has no value marker; ORCL is benchmarked against the Software & Services industry group.

Net Margin (TTM)

For every dollar of sales, both AbbVie (ABBV) at 15.67% and Oracle (ORCL) at 26.36% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

15.67%

Max
18.05%
ABBV
15.67%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

ORCL

Software & Services industry group

26.36%

Max
41.17%
ORCL
26.36%
Q3
15.28%
Median
4.63%
Q1
-5.42%
Min
-33.17%
Loading chart…
AbbVie (ABBV) vs. Oracle (ORCL): A comparison of their net margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

Operating Margin (TTM)

Both AbbVie (ABBV) at 39.59% and Oracle (ORCL) at 35.63% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

39.59%

Max
83.12%
ABBV
39.59%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%

ORCL

Software & Services industry group

35.63%

Max
46.89%
ORCL
35.63%
Q3
17.64%
Median
8.73%
Q1
-2.13%
Min
-30.45%
Loading chart…
AbbVie (ABBV) vs. Oracle (ORCL): A comparison of their operating margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

Profitability Metrics

Profitability metrics for AbbVie (ABBV) and Oracle (ORCL)
MetricABBVORCL
ROE (TTM)--41.19%
ROA (TTM)10.74%6.36%
Net Margin (TTM)15.67%26.36%
Operating Margin (TTM)39.59%35.63%
Gross Margin (TTM)73.72%63.96%

Growth

Revenue Growth

Both AbbVie (ABBV) at 8.57% and Oracle (ORCL) at 17.35% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Loading chart…
AbbVie (ABBV) vs. Oracle (ORCL): A comparison of their Revenue Growth across different time periods.

EPS Growth

Both AbbVie (ABBV) at -0.84% and Oracle (ORCL) at 34.33% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.

Loading chart…
AbbVie (ABBV) vs. Oracle (ORCL): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for AbbVie (ABBV) and Oracle (ORCL)
MetricABBVORCL
Revenue Growth (YoY)8.57%17.35%
Revenue Growth (3Y CAGR)1.75%10.48%
EPS Growth (YoY)-0.84%34.33%
EPS Growth (3Y CAGR)-29.03%23.84%

Financial Strength

Current Ratio (MRQ)

Oracle (ORCL) at 1.17 keeps current ratio within its industry’s typical mid-range, while AbbVie (ABBV) at 0.87 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for ABBV.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.87

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
ABBV
0.87
Min
0.10

ORCL

Software & Services industry group

1.17

Max
5.11
Q3
2.77
Median
1.67
ORCL
1.17
Q1
1.01
Min
0.03
Loading chart…
AbbVie (ABBV) vs. Oracle (ORCL): A comparison of their current ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

Debt / Equity (MRQ)

Only one side’s leverage can be read here: Oracle (ORCL) carries debt-to-equity ratio of 2.52 against its industry range, while AbbVie (ABBV) reports no figure this period.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
1.42
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00
ABBV
--

ORCL

Software & Services industry group

2.52

ORCL
2.52
Max
2.52
Q3
1.13
Median
0.40
Q1
0.07
Min
0.00
Loading chart…
AbbVie (ABBV) vs. Oracle (ORCL): ABBV does not report debt-to-equity ratio, so it has no value marker; ORCL is benchmarked against the Software & Services industry group.

Financial Strength Metrics

Financial strength metrics for AbbVie (ABBV) and Oracle (ORCL)
MetricABBVORCL
Current Ratio (MRQ)0.871.17
Debt / Equity (MRQ)--2.52
Net Debt / EBITDA2.213.84

Dividends

Dividend Yield (TTM)

Both AbbVie (ABBV) at 2.40% and Oracle (ORCL) at 1.74% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.40%

ABBV
2.40%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

ORCL

Software & Services industry group

1.74%

ORCL
1.74%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
AbbVie (ABBV) vs. Oracle (ORCL): A comparison of their dividend yield against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

Dividend Payout Ratio (TTM)

AbbVie (ABBV) reports payout ratio above 100% at 117.35%, meaning dividends exceeded current-period earnings and sustainability needs extra context. Meanwhile Oracle (ORCL) reports 31.35%, ranking against industry peers normally.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

117.35%

ABBV
117.35%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

ORCL

Software & Services industry group

31.35%

ORCL
31.35%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
AbbVie (ABBV) vs. Oracle (ORCL): A comparison of their payout ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

Dividend Metrics

Dividend metrics for AbbVie (ABBV) and Oracle (ORCL)
MetricABBVORCL
Dividend Yield (TTM)2.40%1.74%
Dividend Payout Ratio (TTM)117.35%31.35%

Valuation

P/E Ratio (TTM)

Oracle (ORCL) at 18.20 sits in the cheaper P/E ratio quartile, while AbbVie (ABBV) at 50.05 sits in the richer quartile — a clear split in what investors pay for each dollar of trailing earnings.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

50.05

Max
85.34
ABBV
50.05
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07

ORCL

Software & Services industry group

18.20

Max
112.94
Q3
60.32
Median
32.91
Q1
18.77
ORCL
18.20
Min
6.69
Loading chart…
AbbVie (ABBV) vs. Oracle (ORCL): A comparison of their P/E ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

P/S Ratio (TTM)

On P/S ratio, both AbbVie (ABBV) at 7.80 and Oracle (ORCL) at 5.04 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

7.80

Max
58.18
Q3
25.77
ABBV
7.80
Median
7.30
Q1
3.01
Min
0.01

ORCL

Software & Services industry group

5.04

Max
17.91
Q3
8.78
ORCL
5.04
Median
4.25
Q1
2.23
Min
0.02
Loading chart…
AbbVie (ABBV) vs. Oracle (ORCL): A comparison of their P/S ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

P/B Ratio (MRQ)

AbbVie (ABBV) reports a negative P/B ratio of -112.34, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Oracle (ORCL) reports 5.68, ranking against industry peers normally.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

-112.34

Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59
ABBV
-112.34

ORCL

Software & Services industry group

5.68

Max
16.63
Q3
8.50
ORCL
5.68
Median
4.30
Q1
1.92
Min
-3.90
Loading chart…
AbbVie (ABBV) vs. Oracle (ORCL): A comparison of their P/B ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

Valuation Metrics

Valuation metrics for AbbVie (ABBV) and Oracle (ORCL)
MetricABBVORCL
P/E Ratio (TTM)50.0518.20
P/S Ratio (TTM)7.805.04
P/B Ratio (MRQ)-112.345.68
Free Cash Flow Yield (TTM)3.44%-12.67%